AOC Pharma S.à r.l.

AOC Pharma S.à r.l. appears in our data through filings on Fagron shares, published by FSMA. We count 10 filings; the first trade dates from 20 October 2023 and the latest from 31 December 2024.

No open-market sale appears; the market trades are 10 purchases worth €22.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 5 purchases and no sales.

In size, the median ticket on the buying side is €155k. 7 out of 10 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 14 May 2025, reports an open-market purchase of €85k in Fagron. Every figure here comes from the filings published by FSMA and describes the past, not future prices; it is not investment advice.